Precigen, Inc.
NASDAQ:PGEN
1.13 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.225 | 26.909 | 103.873 | 103.178 | 90.722 | 160.574 | 230.981 | 190.926 | 173.605 | 71.93 | 23.76 | 13.925 | 8.013 |
| Cost of Revenue
| 6.119 | 6.339 | 58.385 | 55.513 | 61.401 | 63.287 | 62.788 | 61.639 | 63.929 | 19.26 | 48.165 | 64.034 | 0 |
| Gross Profit
| 0.106 | 20.57 | 45.488 | 47.665 | 29.321 | 97.287 | 168.193 | 129.287 | 109.676 | 52.67 | -24.405 | -50.109 | 8.013 |
| Gross Profit Ratio
| 0.017 | 0.764 | 0.438 | 0.462 | 0.323 | 0.606 | 0.728 | 0.677 | 0.632 | 0.732 | -1.027 | -3.598 | 1 |
| Reseach & Development Expenses
| 48.614 | 47.17 | 50.141 | 41.644 | 101.879 | 404.586 | 143.207 | 112.135 | 147.483 | 58.983 | 48.165 | 64.185 | 70.228 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 137.807 | 146.103 | 142.318 | 109.057 | 63.649 | 33.618 | 24.897 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 40.415 | 48.006 | 74.122 | 91.704 | 100.844 | 137.807 | 146.103 | 142.318 | 109.057 | 63.649 | 33.618 | 24.897 | 18.3 |
| Other Expenses
| 0 | 1.539 | -0.33 | -0.165 | 3.445 | 0.63 | 1.013 | 1.7 | 1.314 | -0.168 | -0.162 | -0.101 | -0.001 |
| Operating Expenses
| 84.181 | 95.176 | 124.263 | 133.348 | 202.723 | 542.393 | 289.31 | 254.453 | 256.54 | 122.632 | 81.783 | 89.082 | 90.44 |
| Operating Income
| -88.923 | -74.606 | -78.775 | -85.683 | -173.402 | -505.61 | -137.89 | -125.166 | -146.864 | -69.962 | -58.023 | -75.157 | -82.427 |
| Operating Income Ratio
| -14.285 | -2.773 | -0.758 | -0.83 | -1.911 | -3.149 | -0.597 | -0.656 | -0.846 | -0.973 | -2.442 | -5.397 | -10.287 |
| Total Other Income Expenses Net
| -7.439 | -5.36 | -19.562 | -18.351 | -35.285 | -26.245 | 17.802 | -68.985 | 59.886 | -15.757 | 17.115 | -6.717 | -2.853 |
| Income Before Tax
| -96.362 | -79.966 | -96.925 | -103.855 | -208.687 | -536.234 | -129.7 | -194.151 | -86.978 | -85.719 | -40.908 | -81.874 | -85.28 |
| Income Before Tax Ratio
| -15.48 | -2.972 | -0.933 | -1.007 | -2.3 | -3.339 | -0.562 | -1.017 | -0.501 | -1.192 | -1.722 | -5.88 | -10.643 |
| Income Tax Expense
| -0.458 | -0.189 | -0.16 | -0.082 | -0.93 | -21.528 | -2.88 | -3.877 | 1.016 | -0.103 | -9.76 | -0.318 | 0.182 |
| Net Income
| -95.904 | -79.777 | -96.765 | -103.773 | -207.757 | -509.336 | -117.018 | -186.612 | -84.493 | -81.822 | -38.98 | -81.874 | -85.28 |
| Net Income Ratio
| -15.406 | -2.965 | -0.932 | -1.006 | -2.29 | -3.172 | -0.507 | -0.977 | -0.487 | -1.138 | -1.641 | -5.88 | -10.643 |
| EPS
| -0.39 | -0.4 | -0.49 | -0.62 | -1.35 | -3.93 | -0.98 | -1.58 | -0.76 | -0.83 | -0.95 | -14.8 | -15.05 |
| EPS Diluted
| -0.39 | -0.4 | -0.49 | -0.62 | -1.35 | -3.93 | -0.98 | -1.58 | -0.76 | -0.83 | -0.95 | -14.8 | -15.05 |
| EBITDA
| -89.226 | -66.001 | -84.073 | -70.413 | -137.456 | -349.055 | -97.944 | -168.718 | -67.991 | -74.638 | -33.562 | -73.833 | -80.759 |
| EBITDA Ratio
| -14.333 | -2.678 | -0.746 | -0.819 | -1.857 | -2.721 | -0.497 | -0.704 | -0.879 | -1.037 | -2.474 | -4.851 | -9.745 |